Frontiers in Pharmacology (May 2023)
Erratum: Comparison between decitabine and azacitidine for patients with acute myeloid leukemia and higher-risk myelodysplastic syndrome: a systematic review and network meta-analysis
Abstract
No abstracts available.Keywords